Original Research

Published on 17 Dec 2018

South–West of England’s Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

in Respiratory Pharmacology

Shaney L. Barratt
Sarah Mulholland
Khaled Al Jbour
Henry Steer
Markus Gutsche
Noeleen Foley
Rajiv Srivastava
Charles Sharp
Huzaifa I. Adamali

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01480

6,324 views
34 citations

Mini Review

Published on 03 Dec 2018

The Cholinergic Pathways in Inflammation: A Potential Pharmacotherapeutic Target for COPD

in Respiratory Pharmacology

Mitsuhiro Yamada
Masakazu Ichinose

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01426

10,830 views
36 citations

Original Research

Published on 04 Oct 2018

Protective Effects of Anti-IL17 on Acute Lung Injury Induced by LPS in Mice

in Respiratory Pharmacology

Renato Fraga Righetti
Tabata Maruyama dos Santos
Leandro do Nascimento Camargo
Luciana Ritha Cássia Rolim Barbosa Aristóteles
Silvia Fukuzaki
Flávia Castro Ribas de Souza
Fernanda Paula Roncon Santana
Marcus Vinicius Rodrigues de Agrela
Maysa Mariana Cruz
Maria Isabel Cardoso Alonso-Vale

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01021

6,049 views
45 citations

Original Research

Published on 02 Jul 2018

Inhibition of RAGE Attenuates Cigarette Smoke-Induced Lung Epithelial Cell Damage via RAGE-Mediated Nrf2/DAMP Signaling

in Respiratory Pharmacology

Hanbyeol Lee
Jooyeon Lee
Seok-Ho Hong
Irfan Rahman
Se-Ran Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00684

6,110 views
38 citations

Original Research

Published on 18 Jun 2018

Metabolomic Analysis by Nuclear Magnetic Resonance Spectroscopy as a New Approach to Understanding Inflammation and Monitoring of Pharmacological Therapy in Children and Young Adults With Cystic Fibrosis

in Respiratory Pharmacology

Paolo Montuschi
Vincenzina Lucidi
Debora Paris
Enza Montemitro
Rugia Shohreh
Nadia Mores
Dominique Melck
Giuseppe Santini
Fabio Majo
Andrea Motta

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00595

3,720 views
16 citations

Mini Review

Published on 17 May 2018

Proton Pump Inhibitors in IPF: A Call for Clinical Trials

in Respiratory Pharmacology

Yohannes T. Ghebre

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00499

9,745 views
10 citations

Original Research

Published on 01 May 2018

Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway

in Respiratory Pharmacology

Ruijuan Guan
Jian Wang
Ziying Li
Mingjing Ding
Defu Li
Guihua Xu
Tao Wang
Yuqin Chen
Qian Yang
Zhen Long

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00263

6,589 views
55 citations

Original Research

Published on 24 Apr 2018

Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

in Respiratory Pharmacology

Aastha Arora
Vikas Bhuria
Puja P. Hazari
Uma Pathak
Sweta Mathur
Bal G. Roy
Rajat Sandhir
Ravi Soni
Bilikere S. Dwarakanath
Anant N. Bhatt

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00394

8,319 views
18 citations

Mini Review

Published on 20 Apr 2018

Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique

in Respiratory Pharmacology

Michele Marangi
Giuseppa Pistritto

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00396

40,298 views
47 citations

Original Research

Published on 17 Apr 2018

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD

in Respiratory Pharmacology

Paolo Montuschi
Giuseppe Santini
Nadia Mores
Alessia Vignoli
Francesco Macagno
Rugia Shoreh
Leonardo Tenori
Gina Zini
Leonello Fuso
Chiara Mondino

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00258

6,141 views
27 citations

Original Research

Published on 22 Mar 2018

An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines

in Respiratory Pharmacology

Swarna Bale
Pooladanda Venkatesh
Manoj Sunkoju
Chandraiah Godugu

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00248

7,131 views
65 citations

Review

Published on 20 Mar 2018

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension

in Respiratory Pharmacology

Yu Wang
Lingling Yan
Ziming Zhang
Eric Prado
Linchen Fu
Xuefeng Xu
Lizhong Du

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00241

6,749 views
27 citations

Original Research

Published on 31 Jan 2018

Celastrol Alleviates Airway Hyperresponsiveness and Inhibits Th17 Responses in Obese Asthmatic Mice

in Respiratory Pharmacology

Zeyu Zeng
Xixi Lin
Rongying Zheng
Hui Zhang
Weixi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00049

5,432 views
35 citations

Original Research

Published on 17 Jan 2018

PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs

in Respiratory Pharmacology

Zhixin Lei
Qianying Liu
Shuaike Yang
Bing Yang
Haseeb Khaliq
Kun Li
Saeed Ahmed
Abdul Sajid
Bingzhou Zhang
Pin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00002

5,943 views
31 citations

Original Research

Published on 05 Jan 2018

miR449a/SIRT1/PGC-1α Is Necessary for Mitochondrial Biogenesis Induced by T-2 Toxin

in Respiratory Pharmacology

Shijie Ma
Yurong Zhao
Jianwei Sun
Peiqiang Mu
Yiqun Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00954

4,817 views
25 citations

Original Research

Published on 16 Nov 2017

Blockade of Eosinophil-Induced Bronchial Epithelial-Mesenchymal Transition with a Geranyl Acetophenone in a Coculture Model

in Respiratory Pharmacology

Yu Z. Lee
Hui M. Yap
Khozirah Shaari
Chau L. Tham
Mohd R. Sulaiman
Daud A. Israf

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00837

3,487 views
17 citations

Navigation group

Articles

South–West of England’s Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

The Cholinergic Pathways in Inflammation: A Potential Pharmacotherapeutic Target for COPD

Protective Effects of Anti-IL17 on Acute Lung Injury Induced by LPS in Mice

Inhibition of RAGE Attenuates Cigarette Smoke-Induced Lung Epithelial Cell Damage via RAGE-Mediated Nrf2/DAMP Signaling

Metabolomic Analysis by Nuclear Magnetic Resonance Spectroscopy as a New Approach to Understanding Inflammation and Monitoring of Pharmacological Therapy in Children and Young Adults With Cystic Fibrosis

Proton Pump Inhibitors in IPF: A Call for Clinical Trials

Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway

Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD

An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension

Celastrol Alleviates Airway Hyperresponsiveness and Inhibits Th17 Responses in Obese Asthmatic Mice

PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs

miR449a/SIRT1/PGC-1α Is Necessary for Mitochondrial Biogenesis Induced by T-2 Toxin

Blockade of Eosinophil-Induced Bronchial Epithelial-Mesenchymal Transition with a Geranyl Acetophenone in a Coculture Model